Search This Blog

Monday, April 28, 2025

Eton Pharma Submits NDA for Diabetes Med

 - NDA submitted for the treatment of central diabetes insipidus -

- Expected 10-month review; commercial preparations underway for a potential Q1 2026 launch –

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)